project id: TCGA-ESCA; case submitter id: TCGA-JY-A6F8; source center: 23; state: released; a260 a280 ratio: 1.84; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 2.63; rna integrity number: 9.3; age at index: 56; days to birth: -20550; ethnicity: not reported; gender: male; race: white; vital status: Alive; year of birth: 1947; age at diagnosis: 20550; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage I; ajcc pathologic t: T1; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 3714.0; icd 10 code: C15.5; last known disease status: not reported; morphology: 8140/3; primary diagnosis: Adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Lower third of esophagus; synchronous malignancy: No; tissue or organ of origin: Lower third of esophagus; tumor grade: Not Reported; year of diagnosis: 2003; treatment or therapy: no; alcohol history: Yes; is ffpe: false; composition: Not Reported; days to sample procurement: 0; initial weight: 100.0; portion submitter id: TCGA-JY-A6F8-01A-11; percent lymphocyte infiltration: 2.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 20.0; percent tumor cells: 80.0; percent tumor nuclei: 100.0;